178 related articles for article (PubMed ID: 37536546)
1. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem.
Zhou X; Zhang P; Liu N; Zhang X; Lv H; Xu W; Huo M
J Control Release; 2023 Sep; 361():161-177. PubMed ID: 37536546
[TBL] [Abstract][Full Text] [Related]
2. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment.
Yamamoto Y; Kasashima H; Fukui Y; Tsujio G; Yashiro M; Maeda K
Cancer Sci; 2023 Jan; 114(1):16-24. PubMed ID: 36197901
[TBL] [Abstract][Full Text] [Related]
3. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect.
Hu X; Peng X; Zhang Y; Fan S; Liu X; Song Y; Ren S; Chen L; Chen Y; Wang R; Peng J; Shen X; Chen Y
Phytomedicine; 2024 Jan; 123():155214. PubMed ID: 38134861
[TBL] [Abstract][Full Text] [Related]
4. Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System.
Duan H; Liu C; Hou Y; Liu Y; Zhang Z; Zhao H; Xin X; Liu W; Zhang X; Chen L; Jin M; Gao Z; Huang W
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10102-10116. PubMed ID: 35175043
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
8. A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.
Ge W; Yue M; Wang Y; Wang Y; Xue S; Shentu D; Mao T; Zhang X; Xu H; Li S; Ma J; Wang L; Cui J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613599
[TBL] [Abstract][Full Text] [Related]
9. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
11. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
[No Abstract] [Full Text] [Related]
12. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R
Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629
[TBL] [Abstract][Full Text] [Related]
13. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance.
Tajaldini M; Poorkhani A; Amiriani T; Amiriani A; Javid H; Aref P; Ahmadi F; Sadani S; Khori V
Eur J Pharmacol; 2023 Oct; 957():175991. PubMed ID: 37619785
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Zhang T; Ren Y; Yang P; Wang J; Zhou H
Cell Death Dis; 2022 Oct; 13(10):897. PubMed ID: 36284087
[TBL] [Abstract][Full Text] [Related]
15. The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M; Murakami H; Akita H; Kobayashi S; Takahama S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Gotoh K; Doki Y; Yamamoto T; Eguchi H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999632
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.
Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR
Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711
[TBL] [Abstract][Full Text] [Related]
18. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
19. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma.
Luo W; Zhang T
Cancer Lett; 2023 Jul; 567():216279. PubMed ID: 37336287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]